Ticker: Second patient death reported with gene therapy for muscular dystrophy; Salmonella poisoning linked to pistachio cream

Why did OpenAI win the $200 million defense contract? How will SoftBank’s T-Mobile share sale affect the market? What impact did the Senate GOP’s Trump tax bill have? Why is Trump launching a Bitcoin and Ether ETF? How did Israel-Iran conflict influence oil prices today? Why is WhatsApp introducing ads and subscriptions now? What caused the recent surge in AMD’s stock price?

Ticker: Second patient death reported with gene therapy for muscular dystrophy; Salmonella poisoning linked to pistachio cream

bostonherald.com/2025/06/16/ticker-second-patient-death-reported-with-gene-therapy-for-muscular-dystrophy-salmonella-poisoning-linked-to-pistachio-cream

Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy.
Sarepta reported the death over the weekend and provided additional details about its response, which includes pausing shipments…

This story appeared on bostonherald.com, 2025-06-16 20:36:27.